Related Experiment Video
Updated: Jan 21, 2026

Experimental Human Pneumococcal Carriage
Published on: February 15, 2013
In vivo proteomics identifies the competence regulon and AliB oligopeptide transporter as pathogenic factors in
Frank Schmidt1, Niamatullah Kakar2, Tanja C Meyer3
1ZIK-FunGene, Department of Functional Genomics, Interfaculty Institute for Genetics and Functional Genomics, Center for Functional Genomics of Microbes, University Medicine Greifswald, Greifswald, Germany.
Abstract:
Streptococcus pneumoniae (pneumococci) is a leading cause of severe bacterial meningitis in many countries worldwide. To characterize the repertoire of fitness and virulence factors predominantly expressed during meningitis we performed niche-specific analysis of the in vivo proteome in a mouse meningitis model, in which bacteria are directly inoculated into the cerebrospinal fluid (CSF) cisterna magna. We generated a comprehensive mass spectrometry (MS) spectra library enabling bacterial proteome analysis even in the presence of eukaryotic proteins. We recovered 200,000 pneumococci from CSF obtained from meningitis mice and by MS we identified 685 pneumococci proteins in samples from in vitro filter controls and 249 in CSF isolates. Strikingly, the regulatory two-component system ComDE and substrate-binding protein AliB of the oligopeptide transporter system were exclusively detected in pneumococci recovered from the CSF. In the mouse meningitis model, AliB-, ComDE-, or AliB-ComDE-deficiency resulted in attenuated meningeal inflammation and disease severity when compared to wild-type pneumococci indicating the crucial role of ComDE and AliB in pneumococcal meningitis. In conclusion, we show here mechanisms of pneumococcal adaptation to a defined host compartment by a proteome-based approach. Further, this study provides the basis of a promising strategy for the identification of protein antigens critical for invasive disease caused by pneumococci and other meningeal pathogens.
Insights
Streptococcus pneumoniae adaptation to the brain involves specific proteins like ComDE and AliB. These are crucial for virulence in pneumococcal meningitis, offering targets for new therapies.
Area of Science:
- Microbiology
- Infectious Diseases
- Proteomics
Background:
- Streptococcus pneumoniae is a primary cause of bacterial meningitis globally.
- Understanding pneumococcal adaptation within the host is key to developing effective treatments.
Purpose of the Study:
- To identify Streptococcus pneumoniae proteins expressed specifically during meningitis.
- To investigate the role of these proteins in disease pathogenesis.
Main Methods:
- Niche-specific proteome analysis using mass spectrometry (MS) in a mouse meningitis model.
- Direct inoculation of bacteria into cerebrospinal fluid (CSF) for in vivo studies.
- Generation of a comprehensive MS spectra library for accurate bacterial protein identification.
Main Results:
- Identified 249 pneumococcal proteins in CSF isolates, with ComDE and AliB exclusively detected in vivo.
- Mice infected with AliB- or ComDE-deficient pneumococci showed reduced meningeal inflammation and disease severity.
- Demonstrated the critical roles of ComDE and AliB in pneumococcal meningitis pathogenesis.
Conclusions:
- The ComDE and AliB systems are essential for Streptococcus pneumoniae adaptation and virulence in the CSF.
- Proteome-based analysis provides a powerful strategy for identifying virulence factors in invasive bacterial pathogens.
- This research offers potential targets for novel therapeutic interventions against pneumococcal meningitis.
Related Concept Videos
Cranial and Spinal Meninges
Cranial Meninges
These meningeal layers cover the cranium. The dura mater is the outermost layer of cranial meninges. It is a thick and durable membrane of dense...
Facilitated Transport
Transcription Factors
Primary Active Transport
Secondary Active Transport
Proteomics
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term...

